Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.1550 (1.63%) ($7.1550 - $7.1550) on Thu. Oct. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.3% (three month average) | RSI | 35 | Latest Price | $7.1550(1.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(73%) XBI(71%) ARKK(61%) IBB(61%) IBUY(61%) | Factors Impacting EDIT price | EDIT will decline at least -1.65% in a week (0% probabilities). TBT(-23%) UUP(-14%) VXX(-11%) VIXM(-10%) GLD(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.65% (StdDev 3.3%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.8 | 5 Day Moving Average | $7.28(-1.72%) | 10 Day Moving Average | $7.24(-1.17%) | 20 Day Moving Average | $7.8(-8.27%) | To recent high | -22.9% | To recent low | 3.4% | Market Cap | $444m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |